Coffee, caffeine-related genes, and Parkinson's disease: A case-control study

Maurizio F. Facheris, Nicole K. Schneider, Timothy G. Lesnick, Mariza De Andrade, Julie M Cunningham, Walter A Rocca, Demetrius M. Maraganore

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

An inverse association between coffee and Parkinson's disease (PD) has been reported. However, it remains uncertain why some but not all coffee drinkers are less susceptible to PD. We considered the possibility of a pharmacogenetic effect. In our study, we included 1,208 subjects (446 case-unaffected sibling pairs and 158 case-unrelated control pairs) recruited from an ongoing study of the molecular epidemiology of PD in the Upper Midwest (USA). We collected information on lifetime coffee drinking and we studied two genes: ADORA2A, which encodes the major receptor activity of caffeine in the brain (variants rs5751876 and rs3032740), and CYP1A2, which encodes the major rate-limiting step of caffeine metabolism (variants rs35694136 and rs762551). We did not observe significant associations of coffee drinking or of the genetic variants with PD susceptibility, either independently or jointly, in the sample overall and in most strata. Our study neither supports the hypothesis that coffee protects against PD nor provides evidence for a pharmacogenetic effect.

Original languageEnglish (US)
Pages (from-to)2033-2040
Number of pages8
JournalMovement Disorders
Volume23
Issue number14
DOIs
StatePublished - Oct 30 2008

Fingerprint

Coffee
Caffeine
Parkinson Disease
Case-Control Studies
Genes
Pharmacogenetics
Drinking
Cytochrome P-450 CYP1A2
Molecular Epidemiology
Disease Susceptibility
Brain

Keywords

  • Coffee
  • Genes
  • Parkinson's disease

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Coffee, caffeine-related genes, and Parkinson's disease : A case-control study. / Facheris, Maurizio F.; Schneider, Nicole K.; Lesnick, Timothy G.; De Andrade, Mariza; Cunningham, Julie M; Rocca, Walter A; Maraganore, Demetrius M.

In: Movement Disorders, Vol. 23, No. 14, 30.10.2008, p. 2033-2040.

Research output: Contribution to journalArticle

Facheris, Maurizio F. ; Schneider, Nicole K. ; Lesnick, Timothy G. ; De Andrade, Mariza ; Cunningham, Julie M ; Rocca, Walter A ; Maraganore, Demetrius M. / Coffee, caffeine-related genes, and Parkinson's disease : A case-control study. In: Movement Disorders. 2008 ; Vol. 23, No. 14. pp. 2033-2040.
@article{949e11836cf94af48f60ab74afcdf07f,
title = "Coffee, caffeine-related genes, and Parkinson's disease: A case-control study",
abstract = "An inverse association between coffee and Parkinson's disease (PD) has been reported. However, it remains uncertain why some but not all coffee drinkers are less susceptible to PD. We considered the possibility of a pharmacogenetic effect. In our study, we included 1,208 subjects (446 case-unaffected sibling pairs and 158 case-unrelated control pairs) recruited from an ongoing study of the molecular epidemiology of PD in the Upper Midwest (USA). We collected information on lifetime coffee drinking and we studied two genes: ADORA2A, which encodes the major receptor activity of caffeine in the brain (variants rs5751876 and rs3032740), and CYP1A2, which encodes the major rate-limiting step of caffeine metabolism (variants rs35694136 and rs762551). We did not observe significant associations of coffee drinking or of the genetic variants with PD susceptibility, either independently or jointly, in the sample overall and in most strata. Our study neither supports the hypothesis that coffee protects against PD nor provides evidence for a pharmacogenetic effect.",
keywords = "Coffee, Genes, Parkinson's disease",
author = "Facheris, {Maurizio F.} and Schneider, {Nicole K.} and Lesnick, {Timothy G.} and {De Andrade}, Mariza and Cunningham, {Julie M} and Rocca, {Walter A} and Maraganore, {Demetrius M.}",
year = "2008",
month = "10",
day = "30",
doi = "10.1002/mds.22247",
language = "English (US)",
volume = "23",
pages = "2033--2040",
journal = "Movement Disorders",
issn = "0885-3185",
publisher = "John Wiley and Sons Inc.",
number = "14",

}

TY - JOUR

T1 - Coffee, caffeine-related genes, and Parkinson's disease

T2 - A case-control study

AU - Facheris, Maurizio F.

AU - Schneider, Nicole K.

AU - Lesnick, Timothy G.

AU - De Andrade, Mariza

AU - Cunningham, Julie M

AU - Rocca, Walter A

AU - Maraganore, Demetrius M.

PY - 2008/10/30

Y1 - 2008/10/30

N2 - An inverse association between coffee and Parkinson's disease (PD) has been reported. However, it remains uncertain why some but not all coffee drinkers are less susceptible to PD. We considered the possibility of a pharmacogenetic effect. In our study, we included 1,208 subjects (446 case-unaffected sibling pairs and 158 case-unrelated control pairs) recruited from an ongoing study of the molecular epidemiology of PD in the Upper Midwest (USA). We collected information on lifetime coffee drinking and we studied two genes: ADORA2A, which encodes the major receptor activity of caffeine in the brain (variants rs5751876 and rs3032740), and CYP1A2, which encodes the major rate-limiting step of caffeine metabolism (variants rs35694136 and rs762551). We did not observe significant associations of coffee drinking or of the genetic variants with PD susceptibility, either independently or jointly, in the sample overall and in most strata. Our study neither supports the hypothesis that coffee protects against PD nor provides evidence for a pharmacogenetic effect.

AB - An inverse association between coffee and Parkinson's disease (PD) has been reported. However, it remains uncertain why some but not all coffee drinkers are less susceptible to PD. We considered the possibility of a pharmacogenetic effect. In our study, we included 1,208 subjects (446 case-unaffected sibling pairs and 158 case-unrelated control pairs) recruited from an ongoing study of the molecular epidemiology of PD in the Upper Midwest (USA). We collected information on lifetime coffee drinking and we studied two genes: ADORA2A, which encodes the major receptor activity of caffeine in the brain (variants rs5751876 and rs3032740), and CYP1A2, which encodes the major rate-limiting step of caffeine metabolism (variants rs35694136 and rs762551). We did not observe significant associations of coffee drinking or of the genetic variants with PD susceptibility, either independently or jointly, in the sample overall and in most strata. Our study neither supports the hypothesis that coffee protects against PD nor provides evidence for a pharmacogenetic effect.

KW - Coffee

KW - Genes

KW - Parkinson's disease

UR - http://www.scopus.com/inward/record.url?scp=57049162476&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57049162476&partnerID=8YFLogxK

U2 - 10.1002/mds.22247

DO - 10.1002/mds.22247

M3 - Article

C2 - 18759349

AN - SCOPUS:57049162476

VL - 23

SP - 2033

EP - 2040

JO - Movement Disorders

JF - Movement Disorders

SN - 0885-3185

IS - 14

ER -